Synthesis process for compound crizotinib

A technology for crizotinib and synthesis process, applied in the field of chemical medicine, can solve problems such as unfavorable industrial production, large usage of precious metals, waste of enantiomers, etc., and achieves easy control of total cost, low usage of catalyst, and total cost. high yield effect

Inactive Publication Date: 2016-09-07
甘肃皓骏药业有限公司
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Using the Mitsunobu reaction to construct the pyridine-3-position ether bond results in more organic by-products, which are generally separated by column chromatography, and industrial production is difficult; the use of noble metal palladium-catalyzed Miyaura borylation reaction and Suzuki coupl...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis process for compound crizotinib
  • Synthesis process for compound crizotinib
  • Synthesis process for compound crizotinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] (1) preparation of formula (II) compound

[0040]

[0041] Add formula (I) compound (20.7g, 0.1mol), tetrahydrofuran (200mL) and (S)-diphenylprolinol (2.53g, 0.01mol) in the reaction flask, stir at room temperature for 10min until the solid dissolves completely, use Cool to 1°C in an ice-water bath, add NaBH in batches 4 (4.5 g, 0.12 mol). After the addition was complete, the mixture was raised to room temperature and stirred overnight. TLC showed that the reaction of the raw materials was complete, and the reaction solution was poured into a half-saturated aqueous ammonium chloride solution, stirred for 30 minutes, extracted with ethyl acetate, and the organic phases were combined, and successively washed with 1N HCl, 5% NaHCO 3 Washed with saturated brine, dried over anhydrous sodium sulfate, concentrated acid under reduced pressure to dryness, the yield was quantitative, and the remaining light yellow oil was directly used in the next reaction.

[0042] The com...

Embodiment 2

[0073] (1) preparation of formula (II) compound

[0074]

[0075] Add formula (I) compound (20.7g, 0.1mol), methanol (200mL) and (S)-diphenylprolinol (25.3g, 0.1mol) in the reaction flask, stir at room temperature for 10min until the solid dissolves completely, and use Cool in an ice-water bath to 0-5°C, add NaBH in batches 4 (9 g, 0.24 mol). After the addition was complete, the mixture was raised to room temperature and stirred overnight. TLC showed that the reaction of the raw materials was complete, and the reaction solution was poured into a half-saturated aqueous ammonium chloride solution, stirred for 30 minutes, extracted with ethyl acetate, and the organic phases were combined, and successively washed with 1N HCl, 5% NaHCO 3 Washed with saturated brine, dried over anhydrous sodium sulfate, concentrated acid under reduced pressure to dryness, and the residue was purified by column chromatography to obtain a colorless oil, which was shown to be a racemic product by ...

Embodiment 3

[0077] (1) preparation of formula (II) compound

[0078]

[0079] Add formula (I) compound (20.7g, 0.1mol), 2-MeTHF (200mL) and (S)-diphenylprolinol (12.65g, 0.05mol) to the reaction flask, stir at room temperature for 10min until the solid is completely dissolved , cooled to 0°C with an ice-water bath, and added KBH in batches 4 (13.6 g, 0.36 mol). After the addition was complete, the mixture was raised to room temperature and stirred overnight. TLC showed that the reaction of the raw materials was complete, and the reaction solution was poured into a half-saturated aqueous ammonium chloride solution, stirred for 30 minutes, extracted with ethyl acetate, and the organic phases were combined, and successively washed with 1N HCl, 5% NaHCO 3 Wash with saturated brine, dry over anhydrous sodium sulfate, concentrate acid to dryness under reduced pressure, and purify the residue by column chromatography to obtain a colorless oil, which is 99.5% ee by chiral HPLC.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a new synthesis method for crizotinib. An atomic economic reaction is adopted to reduce environmental pollution. A high-optical purity raw material is obtained by chiral prolinol induced chiral reduction; a chiral centre is constructed through an SN2 substitution reaction; post-processing and purification difficulties caused by Mitsunobu reaction are overcome. Malononitrile derivative is constructed by adopting a coupling reaction of malononitrile and bromo-pyridinium derivative; N,N-dicarboamide derivatives are obtained by performing aminolysis on N,N-dimethylamine hydrochloride; in the N,N-dicarboamide derivatives, N,N-dimethylamine serving as an easy-to-leave group and hydrazine perform a ring closing reaction to construct a pyrazolone ring, so that an expected final product, namely crizotinib, is obtained. According to the method, though continuous steps are used, the reaction of each step is high, the optical purity is high, and the total yield is also high. In addition, raw materials used in the synthesis method are low in cost and easily obtained; the using amount of a catalyst is small; total cost is easy to control. An operating process is simple and convenient and easy to control, and is suitable for industrial production.

Description

technical field [0001] The invention relates to the technical field of chemistry and medicine, in particular to a synthesis process of a small molecule drug crizotinib, which is used for treating advanced non-small cell lung cancer. Background technique [0002] The treatment of advanced non-small cell lung cancer (NSCLC) has entered a new era of individualized targeted therapy, and the therapy guided by targeted molecular markers has become a current research hotspot. Following the epidermal growth factor receptor (EGFR) mutation, echinoderm microtubule-associated protein 4 (EML4) and anaplastic lymphoma kinase (ALK) fusion gene, c-Met, Ros sarcoma oncogenic factor (ROS1), etc. The treatment of advanced NSCLC has a new target of guiding significance. Among them, the EML4-ALK fusion gene is caused by the insertion of the short arm of chromosome 2, which makes the kinase domains of the two EML4-ALK molecules combine with each other, and activates the downstream pathway throu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/14
CPCC07D401/14
Inventor 皮红军马军刘兴伟
Owner 甘肃皓骏药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap